Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
51 studies found for:    Open Studies | "Hyperparathyroidism"
Show Display Options
Rank Status Study
1 Recruiting Denosumab in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism
Interventions: Drug: Denosumab;   Other: Placebo
2 Recruiting Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D
Conditions: Primary Hyperparathyroidism;   Hypercalcemia;   Vitamin D Deficiency;   Osteoporosis;   Osteopenia
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Vitamin D3
3 Recruiting Radius Loading in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism, Primary;   Bone Diseases, Metabolic;   Osteoporosis, Postmenopausal;   Bone Loss, Postmenopausal
Interventions: Other: Forearm exercise program;   Other: Walking program
4 Recruiting Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Condition: Primary Hyperparathyroidism
Interventions: Drug: Cinacalcet;   Procedure: parathyroid adenomectomy
5 Recruiting Surgery for Primary Hyperparathyroidism (pHPT) in Patients Older Than 65 Years Compared With Follow-up
Condition: Primary Hyperparathyroidism
Intervention: Procedure: Parathyroid surgery
6 Recruiting Vitamin D Repletion in Primary Hyperparathyroidism
Conditions: Primary Hyperparathyroidism;   Vitamin D Deficiency
Interventions: Dietary Supplement: 10,000 IU Vitamin D3;   Dietary Supplement: Placebo
7 Recruiting Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.
Condition: Secondary Hyperparathyroidism Due to Renal Causes
Interventions: Drug: Paricalcitol;   Drug: Calcifediol
8 Recruiting Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis
Condition: Secondary Hyperparathyroidism
Intervention: Drug: KHK7580
9 Recruiting A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
Condition: Secondary Hyperparathyroidism
Interventions: Drug: ASP7991;   Drug: Cinacalcet;   Drug: Placebo
10 Unknown  Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)
Condition: Secondary Hyperparathyroidism
Intervention: Drug: Cinacalcet HCl
11 Unknown  Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate
Condition: Cured Primary Hyperparathyroidism, Concommitant Osteopenia or Osteoporosis
Interventions: Drug: Strontium Ranelate + Ca/Vitamin-D;   Drug: Placebo
12 Unknown  Primary Hyperparathyroidism: Does a Systematic Treatment Improve the Calcium and Bone Metabolism After Surgery?
Conditions: Primary Hyperparathyroidism;   Bone Metabolism
Intervention: Drug: Calcium and vitamin D
13 Unknown  Lipids Profile in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism
Intervention:
14 Recruiting Safety & Tolerability of Cinacalcet in Pediatric Subjects With Chronic Kidney Disease & Secondary Hyperparathyroidism
Conditions: Chronic Kidney Disease;   Hyperparathyroidism, Secondary
Intervention: Drug: Cinacalcet HCl
15 Unknown  Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism
Condition: Primary Hyperparathyroidism (PHPT)
Intervention:
16 Unknown  Pilot Study: Hypovitaminosis D, Hyperparathyroidism and Hypomagnesemia in Patients With Congestive Heart Failure
Conditions: Congestive Heart Failure;   Hypovitaminosis D;   Hypomagnesemia;   Hyperparathyroidism
Intervention:
17 Not yet recruiting Optimal Anemia Treatment in End Stage Renal Disease (ERSD)
Condition: Hyperparathyroidism, Secondary
Interventions: Drug: standard care;   Drug: Optimal (I. iPTH control: Zemplar®,Mimpara®; phosphorous control: Renvela®, Phoslo®, Osvaren®, Foznol®,Maalox®; calcium control: calcium and vitamin D
18 Recruiting EC17 for Intraoperative Imaging for Parathyroidectomy
Condition: Primary Hyperparathyroidism
Intervention: Drug: EC17
19 Recruiting To Assess the Long-term Safety of AMG 416 in the Treatment of SHPT in Subjects With CKD on Hemodialysis
Condition: Hyperparathyroidism, Secondary
Intervention: Drug: AMG 416
20 Recruiting Studies of Elevated Parathyroid Activity
Conditions: Hyperparathyroidism;   Hypocalcemia;   Parathyroid Neoplasm
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years